VEGF also involves in tumor cell growth and immunosuppression (Sheng et al., 2019; Wilky et al., 2019), suggesting the benefit of a combination therapy of AATs with immune checkpoint inhibitors. This evidence concerns the gene VEGFA and neoplasm.